Press Releases on January 3, 2024 - EIN Presswire - Press Release Distribution Service

Published on January 3, 2024 - 12:00 GMT

Braemont Capital Announces Firm Promotions and Industry Award Honors

Ben Eckholm Promoted to Senior Associate Founder and Managing Partner Robert Covington Named to D CEO’s 2024 Dallas 500 List DALLAS, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Braemont Capital (“Braemont”), a relationship-driven investment firm that partners with …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 3, 2024 - 12:00 GMT

GRIID Infrastructure Inc. Receives Commencement of Delisting Notice From the NYSE

CINCINNATI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- GRIID Infrastructure Inc. (“GRIID” or the “Company”), an American bitcoin mining company that leverages a low-cost, low-carbon energy mix to manage and operate vertically integrated bitcoin mining facilities, …

Distribution channels: Banking, Finance & Investment Industry ...

Published on January 3, 2024 - 12:00 GMT

POET Technologies Announces ZKTel as Customer and Collaborator

TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 3, 2024 - 12:00 GMT

Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia

NDA submitted to FDA and MAA validated by EMA in December 2023 Submissions are based on positive results from Phase 3 registrational ACTION-Galactosemia Kids study demonstrating consistent long-term clinical outcomes benefit across a range of functional …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2024 - 12:00 GMT

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK

– Company Expands Canadian Cannabis Exports to Fourth Overseas Medical Cannabis Market – VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the …

Distribution channels: Media, Advertising & PR ...

Published on January 3, 2024 - 12:00 GMT

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute ...

FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced the completion of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 3, 2024 - 12:00 GMT

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation and potential clinically meaningful activity of fosgonimeton Potential first-in-class approach focused on HGF …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2024 - 12:00 GMT

Important Update on Listing Status and Strategic Direction

Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2024 - 12:00 GMT

Akoustis to Attend CES 2024 Conference in Las Vegas from January 9-12

Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless …

Distribution channels:

Published on January 3, 2024 - 12:00 GMT

Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, announced today that Verge Genomics’ co- …

Distribution channels:

Published on January 3, 2024 - 12:00 GMT

Troilus Announces Agreement for Strategic Sale of Non-Core Mike Lake Properties in Yukon to Prospector Metals; Retains ~20% ...

MONTREAL, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) (“Troilus” or the “Company”) announces it has entered into an agreement for the strategic divestiture of its non-core Mike Lake properties (“Mike Lake” or “ …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 3, 2024 - 12:00 GMT

Acreage Enters New York Adult-Use Market with First Wholesale Product Sale

The Botanist products expected to hit participating adult-use dispensary shelves the week of January 8th Full menu of The Botanist products available for purchase to eligible adult-use dispensaries NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Acreage …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on January 3, 2024 - 12:00 GMT

Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-102 SL for the Management of ...

TNX-102 SL is a Non-Opioid Analgesic that Demonstrated Daily Pain Reduction Over Placebo (Primary Endpoint, p = 0.00005) and Showed Positive Effects Across All Six Key Secondary Endpoints in Recently Reported Phase 3 Trial Company Plans to Submit a New …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2024 - 12:00 GMT

Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance transformational therapies against otherwise undruggable disease-causing …

Distribution channels:

Published on January 3, 2024 - 12:00 GMT

ProMIS Neurosciences, Inc. Announces Leadership Transition

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 3, 2024 - 12:00 GMT

Anfield Prepares For An Increase in Mill Production Capacity With the Acquisition of Additional DOE leases in Colorado

VANCOUVER, British Columbia , Jan. 03, 2024 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that its subsidiary, Highbury Resources, Inc. (“Highbury”) has entered into a …

Distribution channels: ...

Published on January 3, 2024 - 12:00 GMT

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 3, 2024 - 12:00 GMT

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders

SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, issues the following letter to shareholders: Dear …

Distribution channels:

Published on January 3, 2024 - 12:00 GMT

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of ...

Appointment brings more than 30 years of medical technology general management and commercial leadership experience to the InspireMD team Reports inducement grant under NASDAQ listing rule 5635(c)(4) TEL AVIV, Israel and MIAMI, Jan. 03, 2024 (GLOBE …

Distribution channels:

Published on January 3, 2024 - 12:00 GMT

BIMI Announces Results of 2023 Annual General Meeting of Stockholders

New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 …

Distribution channels: Business & Economy, Media, Advertising & PR ...